Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.
AUTOR(ES)
Fields, R A
RESUMO
Anticardiolipin antibody (aCL) has been associated with thromboembolic phenomena, including stroke, in certain patients with systemic lupus erythematosus (SLE); however, the relation between this antibody and the central nervous system manifestations of SLE is unknown. Serum samples and cerebrospinal fluid from five patients with SLE and acute central nervous system manifestations were assayed for the presence of aCL. Anticardiolipin antibody was identified in sera from four of the five patients but in none of the cerebrospinal fluid samples. Nuclear magnetic resonance imaging showed 'infarct-like' lesions in these four patients. This preliminary study suggests that a correlation between serum aCL and cerebral infarcts in central nervous system lupus may potentially exist. From this limited study it seems unlikely that aCL has a direct pathogenic role in the diffuse encephalopathy of acute central nervous system lupus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003990Documentos Relacionados
- Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus.
- Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.
- Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus.
- Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.
- Systemic lupus erythematosus, repeated abortions, and thrombocytopenia.